BIOLASE Inc. (NASDAQ:BIOL) shares traded -9.46% lower at $0.14 on Wall Street last session.
In accordance with the data, 4 analysts cover BIOLASE Inc. (NASDAQ:BIOL). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $10.00 and a low of $1.00, we find $1.75. Given the previous closing price of $0.15, this indicates a potential upside of 1066.67 percent. BIOL stock price is now -48.32% away from the 50-day moving average and -89.98% away from the 200-day moving average. The market capitalization of the company currently stands at $3.82M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
It has been rated a hold by 0 analysts and a buy by 4. Brokers who have rated the stock have averaged $3.63 as their price target over the next twelve months.
.
In other news, LORD JONATHAN T MD, Director sold 3,537 shares of the company’s stock on Dec 07. The stock was sold for $2,653 at an average price of $0.75. Upon completion of the transaction, the Director now directly owns 59,925 shares in the company, valued at $8389.5. Insiders disposed of 3,537 shares of company stock worth roughly $495.18000000000006 over the past 1 year. A total of 0.90% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in BIOL stock. A new stake in BIOLASE Inc. shares was purchased by AWM INVESTMENT COMPANY, INC. during the first quarter worth $1,248,000. ZHANG FINANCIAL LLC invested $3,000 in shares of BIOL during the first quarter. In the first quarter, BAADER BANK AKTIENGESELLSCHAFT acquired a new stake in BIOLASE Inc. valued at approximately $1,000. In total, there are 30 active investors with 20.70% ownership of the company’s stock.
BIOLASE Inc. (NASDAQ: BIOL) opened at $0.1500 on Tuesday. During the past 12 months, BIOLASE Inc. has had a low of $0.10 and a high of $5.94. As of last week, the company has a debt-to-equity ratio of 1.70, a current ratio of 1.70, and a quick ratio of 0.70. The fifty day moving average price for BIOL is $0.2648 and a two-hundred day moving average price translates $1.3690 for the stock.
The latest earnings results from BIOLASE Inc. (NASDAQ: BIOL) was released for Mar, 2023. According to the Medical Devices Company, earnings per share came in at -$0.18, beating analysts’ expectations of -$0.2 by 0.02. This compares to -$0.78 EPS in the same period last year. The net profit margin was -60.90% and return on equity was -244.90% for BIOL. The company reported revenue of $10.47 million for the quarter, compared to $10.17 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2.96 percent. For the current quarter, analysts expect BIOL to generate $15.11M in revenue.
Moreover, the firm recently paid out its quarterly dividend on 08/30/2004. Investors who held shares on 08/16/2004 were paid a $0.01 dividend.
BIOLASE Inc.(BIOL) Company Profile
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
